A Systematic Review of Indications and Clinical Outcomes of Electrochemotherapy in Pancreatic Ductal Adenocarcinoma
Cancers · 26.01.2025 · 17 (3) · 408
DOI: 10.3390/cancers17030408 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.01.2025. Verfasst von Gianluca Rompianesi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Division of Minimally Invasive and Robotic HPB S and Gery, Transplantation Service, Federico II Universi…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pancreatic ductal adenocarcinoma (PDAC) is one of the most difficult cancers to treat, with a dismal 5-year survival rate of only 8–10%. This challenging prognosis highlights the urgent need for innovative therapeutic approaches to improve outcomes for patients with PDAC. Electrochemotherapy (ECT), which enhances intracellular chemotherapeutic uptake via electric pulses, has been explored for resectable, borderline resectable (BR), locally advanced (LA), recurrent, and metastatic PDAC, either as a complement to conventional treatments or as an alternative when these are not feasible or effective, offering possible benefits in symptomatic palliation and local tumor control.
Methods
A systematic review was performed in accordance with PRISMA guidelines for studies assessing the efficacy of ECT in PDAC. After searching Embase, PubMed/MEDLINE, Scopus, and Web of Science, five studies with a combined total of 43 patients in various disease stages were identified.
Results
ECT showed promise in improving tumor control, alleviating cancer-related pain, and improving quality of life. One study noted a trend towards tumor size reduction of 8.3% at one-month and 16.1% at six-months follow-up (p = 0.211 and p = 0.315), although these findings were derived from studies conducted without specific comparative control groups. Severity of complication was mainly mild (Clavien–Dindo I-II), while severe complications occurred in only 2.3% of patients. Median overall survival was reported in two studies as 8 months (range 2–19) and 11.5 months (range 1–74). ECT showed efficacy for symptom management, with 60% of patients reporting reduced pain/discomfort and 40% showing enhanced quality of life in one study, while another reported pain scores as decreasing from 6 to 3 at one month and to 2 at six months.
Conclusions
ECT appears to be a new promising and safe adjunct treatment modality in PDAC management across different disease stages, with potential benefits in tumor control, cancer-related pain reduction, and quality of life. Further studies are warranted to validate these findings and identify patients who could benefit most.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Medicine and Surgery, Division of Minimally Invasive and Robotic HPB S and Gery, Transplantation Service, Federico II University Hospital, Via Sergio Pansini 5, 80131 Naples, Italy.
- Department of Public Health, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.
ORCID-Profile: Giuseppe Loiaco, Roberto Montalti
Zitieren
APA
Rompianesi, G., Loiaco, G., Rescigno, L., Benassai, G., Giglio, M. C., Campanile, S., Caggiano, M., Montalti, R., & Troisi, R. I. (2025). A Systematic Review of Indications and Clinical Outcomes of Electrochemotherapy in Pancreatic Ductal Adenocarcinoma. Cancers, 17(3), 408. https://doi.org/10.3390/cancers17030408
Vancouver
Rompianesi G, Loiaco G, Rescigno L, Benassai G, Giglio MC, Campanile S, et al. A Systematic Review of Indications and Clinical Outcomes of Electrochemotherapy in Pancreatic Ductal Adenocarcinoma. Cancers. 2025;17(3):408. doi:10.3390/cancers17030408
BibTeX
@article{Rompianesi2025,
author = {Rompianesi, Gianluca and Loiaco, Giuseppe and Rescigno, Luigi and Benassai, Gianluca and Giglio, Mariano Cesare and Campanile, Silvia and Caggiano, Marcello and Montalti, Roberto and Troisi, Roberto Ivan},
title = {A Systematic Review of Indications and Clinical Outcomes of Electrochemotherapy in Pancreatic Ductal Adenocarcinoma},
journal = {Cancers},
year = {2025},
volume = {17},
number = {3},
pages = {408},
doi = {10.3390/cancers17030408}
}
EUVIMED